Переходьте в офлайн за допомогою програми Player FM !
Biomarkers, patient selection, and immunotherapy at ESMO Gynae 2023
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on October 25, 2024 14:05 ()
What now? This series will be checked again in the next hour. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 374905006 series 2424442
In this episode, we’ll hear from Marcia Hall, Eric Pujade-Lauraine, and Mansoor Raza Mirza, who will share their expertise and insights on the latest developments in gynecological cancer research and treatment from ESMO Gynae 2023.
First, we will hear about a study exploring the use of circulating tumor cells as a potential biomarker for predicting response to therapy. Dr Hall discusses how this study has the potential to revolutionize cancer treatment and diagnosis, and what the implications of these findings are for future research.
Prof. Pujade-Lauraine updates us on the findings from the PAOLA-1 trial, which evaluated the use of maintenance olaparib plus bevacizumab in patients with ovarian cancer. He discuss the importance of patient selection in ovarian cancer, and how these updated findings can inform treatment decisions for patients.
Finally, Dr. Mirza shares his insights on the potential of combination therapies, personalized medicine, and immunotherapy in the treatment of endometrial cancer. He discusses how these new approaches are changing the way we think about treatment, and what the future holds for patients with endometrial cancer.
The post Biomarkers, patient selection, and immunotherapy at ESMO Gynae 2023 appeared first on VJOncology.
179 епізодів
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on October 25, 2024 14:05 ()
What now? This series will be checked again in the next hour. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 374905006 series 2424442
In this episode, we’ll hear from Marcia Hall, Eric Pujade-Lauraine, and Mansoor Raza Mirza, who will share their expertise and insights on the latest developments in gynecological cancer research and treatment from ESMO Gynae 2023.
First, we will hear about a study exploring the use of circulating tumor cells as a potential biomarker for predicting response to therapy. Dr Hall discusses how this study has the potential to revolutionize cancer treatment and diagnosis, and what the implications of these findings are for future research.
Prof. Pujade-Lauraine updates us on the findings from the PAOLA-1 trial, which evaluated the use of maintenance olaparib plus bevacizumab in patients with ovarian cancer. He discuss the importance of patient selection in ovarian cancer, and how these updated findings can inform treatment decisions for patients.
Finally, Dr. Mirza shares his insights on the potential of combination therapies, personalized medicine, and immunotherapy in the treatment of endometrial cancer. He discusses how these new approaches are changing the way we think about treatment, and what the future holds for patients with endometrial cancer.
The post Biomarkers, patient selection, and immunotherapy at ESMO Gynae 2023 appeared first on VJOncology.
179 епізодів
Wszystkie odcinki
×Ласкаво просимо до Player FM!
Player FM сканує Інтернет для отримання високоякісних подкастів, щоб ви могли насолоджуватися ними зараз. Це найкращий додаток для подкастів, який працює на Android, iPhone і веб-сторінці. Реєстрація для синхронізації підписок між пристроями.